Study Evaluating AGG-523 in Subjects With Osteoarthritis

Wyeth

Status and phase: Completed; Phase 1

Conditions: Osteoarthritis

Treatments: Drug: AGG-523

Study type: Interventional

Funder types: Industry

Identifiers

NCT00427687

3189A1-104

Details and patient eligibility

About

This study will evaluate the effect of AGG-523 administration on biomarkers related to osteoarthritis. Safety and tolerability of AGG-523 will also be assessed.

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion:

• Mild to moderate Osteoarthritis of the target knee.
• Subjects must be generally healthy but enrolled with stable chronic illness if well controlled.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind